|
|
|
|
| LEADER |
01610nam a2200253 u 4500 |
| 001 |
EB002002201 |
| 003 |
EBX01000000000000001165102 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 100 |
1 |
|
|a Lachance, Chantelle
|
| 245 |
0 |
0 |
|a Non-pharmacological and pharmacological interventions for smoking cessation programs in youth
|h Elektronische Ressource
|b a review of clinical effectiveness and guidelines
|c Chantelle Lachance and Nina Frey
|
| 250 |
|
|
|a Version 1.0
|
| 260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c February 24, 2020, 2020
|
| 300 |
|
|
|a 1 PDF file (40 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 700 |
1 |
|
|a Frey, Nina
|e [author]
|
| 710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK562834
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a To inform policy decisions about using pharmacotherapy and non-pharmacotherapy for smoking cessation among youth, specific evidence is required. As such, this report aims to review the clinical effectiveness of using a combination of pharmacological and nonpharmacological smoking cessation interventions or non-pharmacological smoking cessation interventions alone for youth. The current report also aims to review evidence-based guidelines regarding smoking cessation interventions for youth
|